v3.26.1
Consolidated Balance Sheets - USD ($)
Jun. 30, 2026
Jun. 30, 2025
Current assets    
Cash and cash equivalents $ 3,992,312 $ 1,019,909
Accounts receivable, net 848,464 594,614
Inventories, net 418,577 635,215
Research and development tax incentive receivable 806,951 734,408
Assets held for sale 327,500
Prepaid expenses and other current assets 1,030,932 826,976
Total current assets 7,097,236 4,138,622
Property and equipment, net 294,399 251,325
Operating lease right-of-use assets 1,751,040 69,520
Intangibles, net 2,799,161 3,790,319
Total assets 11,941,836 8,249,786
Current liabilities    
Accounts payable and accrued expenses 4,130,213 4,534,246
Current portion of operating lease liabilities 147,005 84,659
Current employee benefit liabilities 651,706 534,990
Notes payable 197,146
Total current liabilities 4,928,924 5,351,041
Employee benefit liabilities, less current portion 49,931 84,921
Operating lease liabilities, less current portion 1,672,155
Total liabilities 6,651,010 5,435,962
Commitments and contingencies (Note 15)
Shareholders’ equity    
Common stock, $0.01 par value, 100,000,000 shares authorized, 2,905,615 and 2,905,603 shares issued and outstanding, as of June 30, 2026, respectively; 732,339 and 732,327 shares issued and outstanding, as of June 30, 2025, respectively [1] 29,056 7,324
Treasury stock, at cost, 12 shares as of  June 30, 2026 and 2025, respectively [1] (1) (1)
Additional paid-in capital [1] 80,992,006 65,849,822
Accumulated deficit (74,964,040) (62,533,065)
Accumulated other comprehensive loss (546,186) (327,944)
Total consolidated Intelligent Bio Solutions Inc. equity 5,510,835 2,996,136
Non-controlling interest (220,009) (182,312)
Total shareholders’ equity 5,290,826 2,813,824 [2]
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 11,941,836 $ 8,249,786
[1] Common stock and per share amounts have been retroactively adjusted to reflect a 1-for-10 reverse stock split effected on December 15, 2025, throughout the consolidated financial statements unless otherwise stated.
[2] Common stock and per share amounts have been retroactively adjusted to reflect a 1-for-10 reverse stock split effected on December 15, 2025, throughout the consolidated financial statements unless otherwise stated.